Preview of US Stock Market | The three major stock index futures all rose together, with the performance of ASM ranking first in the AI industry.
On October 15th (Wednesday), before the open of the U.S. stock market, the futures of the three major U.S. stock indexes all rose.
1. Before the US stock market opened on Wednesday, the futures of the three major US stock indexes all rose. As of the time of writing, the Dow Jones futures were up 0.56%, the S&P 500 index futures were up 0.76%, and the Nasdaq futures were up 0.99%.
2. As of the time of writing, the Germany DAX index rose by 0.02%, the UK FTSE 100 index fell by 0.38%, the France CAC 40 index rose by 2.30%, and the Europe Stoxx 50 index rose by 1.28%.
3. As of the time of writing, WTI crude oil rose by 0.73% to $59.13 per barrel. Brent crude oil rose by 0.51% to $62.7 per barrel.
Market News:
Powell hints at further rate cuts this month, emphasizing that the downside risks to the job market remain unchanged. Federal Reserve Chairman Powell stated that the Fed is expected to cut interest rates by another 25 basis points later this month, despite the severe impact of the US government shutdown on its assessment of the economic situation. Powell mentioned the slow pace of hiring several times, indicating that this situation could worsen further.
Copper prices rebounded after Powell's dovish remarks, with industry insiders seeing prices rising to $12,000 per ton. After Federal Reserve Chairman Powell hinted at another rate cut this month, copper prices rebounded. Some industry insiders even suggest that copper prices could reach $12,000 per ton.
US government shutdown puts inflation data at risk, with fears that the accuracy of October CPI data may be compromised. If the US government shutdown continues, one of the country's most important inflation statistics may not only be delayed but also suffer from compromised data quality.
JP Morgan warns that the US is "slowly heading towards bankruptcy," with soaring debt levels and tariffs posing challenges. JP Morgan's David Kelly warned that the US is slowly "moving towards bankruptcy," as the national debt exceeds $37.8 trillion, with interest expenses exceeding $1.2 trillion.
Stock News:
Morgan Stanley's Q3 performance exceeded expectations, with investment banking business rebounding particularly impressively. Morgan Stanley's net revenue in the third quarter increased by 18% year-over-year to $18.22 billion, surpassing the estimated $16.64 billion.
Abbott Laboratories' Q3 revenue of approximately $11.37 billion fell below expectations. Abbott Laboratories' quarterly revenue was slightly lower than analysts' average expectation of $11.40 billion, largely due to weak trends in their diagnostics and nutritional businesses.
Dollar Tree, Inc. expects earnings per share to grow at a rate of 12-15% over the next three years. The company also predicts that by 2026, earnings per share will grow by "nearly 20%" due to cost advantages.
Mergers and acquisitions activity benefits Wall Street, with Bank of America Corp's third-quarter performance exceeding expectations. Bank of America Corp's third-quarter revenue of $28.09 billion grew by 11% year-over-year, with earnings per share of $1.06 outperforming market expectations.
Information Technology:
ASML Holding NV ADR's Q3 orders exceeded expectations due to the intense competition in the AI arms race. ASML Holding NV ADR's orders in the quarter amounted to 54 billion euros, exceeding analysts' expectations of 49 billion euros.
Apple Inc.'s iPhone 17 shipments in China increased by 0.6% in Q3. Apple Inc.'s iPhone 17 managed to attract cost-conscious consumers, resulting in a slight growth in shipments. In the third quarter, Apple Inc. ranked second in terms of market share with a market share of 15.8%.
Medical News:
Eli Lilly's oral weight loss drug successfully passed Phase III clinical trials. Eli Lilly announced that its oral weight loss drug orforglipron has the potential to become a new standard in the treatment of type 2 diabetes. In the trials, orforglipron showed a significant reduction in the diabetes biomarker HbA1c levels compared to Astrazeneca PLC's Farxiga.
Related Articles

US Stock Market Move | Popular Chinese concept stocks collectively rose sharply, with New Oriental Education & Technology Group, Inc. Sponsored ADR (EDU.US) jumping more than 8%.

US Stock Market Move | Gold stock continues to strengthen, Kinross Gold Corporation (KGC.US) rises more than 7%

US Stock Market Move | Omeros Corporation (OMER.US) soars 150% following asset purchase and license agreement with Novo Nordisk A/S Sponsored ADR Class B.
US Stock Market Move | Popular Chinese concept stocks collectively rose sharply, with New Oriental Education & Technology Group, Inc. Sponsored ADR (EDU.US) jumping more than 8%.

US Stock Market Move | Gold stock continues to strengthen, Kinross Gold Corporation (KGC.US) rises more than 7%

US Stock Market Move | Omeros Corporation (OMER.US) soars 150% following asset purchase and license agreement with Novo Nordisk A/S Sponsored ADR Class B.
